Menopausal hormonal therapy or non-hormonal treatment: rational choice

• Main Authors: T Yu Pestrikova (Author), E A Yurasova (Author), T V Yachinskaya (Author), T D Kovalyova (Author)
• Format: Book
• Published: IP Berlin A.V., 2015-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.
• Notes: 2079-5696; 2079-5831
• Keywords: climacteric syndrome; menopausal hormonal therapy (a combination of estradiol 1 mg /drospirenone 2 mg); arterial pressure; Gynecology and obstetrics; RG1-991
• Source: Гинекология, Vol 17, Iss 3, Pp 34-39 (2015)

Patients with the "climacteric syndrome" diagnosis make only 1,0% in structure of the general incidence of the women who visit the female consultation, and 1.6% - total of the patients consisting on the dispensary account. The patients who are health workers ask for medical care less than managers, teachers. Patients with the diagnosis of a climacteric syndrome had a certain relation to reception of the menopausal hormonal therapy (MHT). So, 22.69% of patients initially feel fear of reception of hormonal preparations; 16.81% - pass to reception of MHT after absence of effect from reception of non-hormonal therapy. Only 16.81% of patients have contraindications to reception of MHT.Purpose of MHT (a combination of estradiol to 1 mg / drospirenone 2 mg) renders high medical effect at patients with a climacteric syndrome (p